PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 52 filers reported holding PASSAGE BIO INC in Q4 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,483 | +22689.1% | 13,203 | +38732.4% | 0.00% | – |
Q1 2024 | $46 | -99.5% | 34 | -99.8% | 0.00% | – |
Q3 2023 | $9,031 | +273.3% | 13,725 | +433.8% | 0.00% | – |
Q2 2023 | $2,419 | +7459.4% | 2,571 | -92.2% | 0.00% | -100.0% |
Q1 2023 | $32 | -46.7% | 33,049 | -24.2% | 0.00% | -50.0% |
Q4 2022 | $60 | -99.9% | 43,596 | +4.7% | 0.00% | +100.0% |
Q3 2022 | $52,000 | +2.0% | 41,625 | +89.9% | 0.00% | 0.0% |
Q2 2022 | $51,000 | +6.2% | 21,919 | +41.2% | 0.00% | – |
Q1 2022 | $48,000 | +380.0% | 15,523 | +865.4% | 0.00% | – |
Q4 2021 | $10,000 | -54.5% | 1,608 | -26.1% | 0.00% | -100.0% |
Q3 2021 | $22,000 | -72.8% | 2,177 | -64.6% | 0.00% | -50.0% |
Q2 2021 | $81,000 | +47.3% | 6,142 | +97.0% | 0.00% | +100.0% |
Q1 2021 | $55,000 | +139.1% | 3,118 | +250.7% | 0.00% | 0.0% |
Q4 2020 | $23,000 | -85.8% | 889 | -92.8% | 0.00% | -50.0% |
Q3 2020 | $162,000 | +671.4% | 12,382 | +1508.1% | 0.00% | +100.0% |
Q2 2020 | $21,000 | +950.0% | 770 | +427.4% | 0.00% | – |
Q1 2020 | $2,000 | – | 146 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $49,399,000 | 20.45% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,185,869 | $11,811,000 | 9.97% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $24,879,000 | 7.18% |
FRAZIER MANAGEMENT LLC | 5,009,219 | $49,892,000 | 3.99% |
Orbimed Advisors | 6,962,899 | $69,350,000 | 0.76% |
Boxer Capital, LLC | 1,928,315 | $19,206,000 | 0.67% |
Vivo Capital, LLC | 539,263 | $5,371,000 | 0.24% |
Logos Global Management LP | 125,010 | $1,245,000 | 0.09% |
Weiss Multi-Strategy Advisers LLC | 336,034 | $3,347,000 | 0.07% |
Virtus ETF Advisers LLC | 14,687 | $146,000 | 0.06% |